Abiopharma

(10% Negative) Zymeworks Inc (ZYME) Announces Delay in Ziihera Development Timeline Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

📋 DAVID J BORGES (Officer) plans to sell 30K shares of OMEROS CORPORATION (at $12.72 each, total $382K) Filed: Jan 12, 2026 | ID: 000358

Douglass Brian Robb 🟢 acquired 4.4K shares (1 derivative) of REPLIGEN CORP (RGEN) at $163.86 Transaction Date: Dec 31, 2025 | Filing ID: 010470

Scorpius Holdings Inc. (SCPX) Files Form 10-Q

(99% Neutral) Option Care Health Inc (OPCH) Reports Q1 2026 Financial Results

New Form DEFA14A - Avidity Biosciences, Inc. Filed: 2026-01-12 AccNo: 0001193125-26-010464 Size: 42 KB

(99% Neutral) GeoVax Labs Inc. (GOVX) Announces Executive Changes

New Form 3 - REPLIGEN CORP Filed: 2026-01-12 AccNo: 0001193125-26-010463 Size: 22 KB

Thermo Fisher Scientific - Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance

(99% Positive) Allurion Technologies Inc (ALUR) Provides Update on results for metabolically healthy weight loss

(99% Neutral) BioAtla Inc (BCAB) Announces Business Combination

Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer

Charles River Laboratories Provides Business Updates

Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance

(10% Negative) BioCryst Pharmaceuticals Inc (BCRX) Reports Q1 2026 Financial Results